Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ValiRx Share Price
  4. ValiRx Share Regulatory News
  5. Issue of Equity

Pin to quick picksValiRx Regulatory News (VAL)

ValiRx Information

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.19    0.00 (0.00%)
Bid:
0.18
Ask:
0.20
Spread: 0.02 (11.111%)
Market Cap: £1.41m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Issue of Equity

5 Mar 2010 15:00

RNS Number : 1767I
ValiRx PLC
05 March 2010
 



ValiRx plc

 

(the "Company")

 

Issue of equity

 

The Company announces that it has issued 3,600,000 new ordinary shares in the Company ("Ordinary Shares") at 1p per share in lieu of fees owed. The admission of 3,600,000 new Ordinary Shares to trading on AIM is expected to occur on 11 March, 2010. On admission, the Company will have 157,945,030 Ordinary Shares in issue.

 

Enquiries:

 

ValiRx plc

Dr. Satu Vainikka

 

Tel: +44 (0) 20 3008 4416

 

WH Ireland Limited - Nominated Adviser & Broker

Adrian Kirk

 

Tel: +44 (0) 161 832 2174

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZELFBBXFZBBV
12345678910
Date   Source Headline
15th Jan 202512:47 pmRNSHolding(s) in Company
15th Jan 202511:29 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
9th Jan 202511:37 amRNSHolding(s) in Company
9th Jan 202511:14 amRNSHolding(s) in Company
8th Jan 20257:00 amRNSHolding(s) in Company
2nd Jan 202511:45 amRNSHolding(s) in Company
31st Dec 20241:06 pmRNSHolding(s) in Company
31st Dec 20248:39 amRNSUpdate on proposed sub-license of VAL201
30th Dec 20241:30 pmRNSResult of GM, Issue of Equity, Warrants and TVR
20th Dec 20247:00 amRNS-RValiRx launches new interactive investor website
10th Dec 20244:45 pmRNSBroker Offer Results & Director/PDMR Subscription
10th Dec 20243:03 pmRNSPosting of Circular and Notice of General Meeting
9th Dec 20247:00 amRNSConditional Fundraising & Launch of Broker Offer
22nd Nov 20247:00 amRNSInaphaea award of HEIF Funding and PhD sponsorship
20th Nov 20247:00 amRNSUpdate on proposed sub-license of VAL401
19th Nov 20247:00 amRNSContract Award
18th Nov 20247:00 amRNSFirst Sale of New Product Line
30th Oct 20247:00 amRNSUpdate on proposed sub-license of VAL201
18th Oct 20247:00 amRNSDirectorate Change
14th Oct 20247:00 amRNSInvestor Webinar
7th Oct 20247:00 amRNSInaphaea Co-Marketing Agreement
27th Sep 20247:00 amRNSHalf-year Report
26th Sep 20247:00 amRNSConclusion of Evaluation Project
24th Sep 20247:00 amRNSInaphaea Co-Marketing Agreement
18th Sep 20247:00 amRNSInaphaea Evaluation and Commercial Use Agreement
16th Sep 20247:00 amRNSInaphaea Co-Marketing Agreement
9th Sep 20247:00 amRNSInaphaea Evaluation and Commercial Use Agreement
9th Sep 20247:00 amRNSInvestor Evening
27th Aug 20247:00 amRNSInaphaea Evaluation and Commercial Use Agreement
12th Aug 20247:00 amRNSDirectorate Change
25th Jul 20247:00 amRNSDirectorate Changes
3rd Jul 20248:51 amRNSProposed Director Appointment
20th Jun 20245:56 pmRNSResult of AGM
19th Jun 202411:33 amRNSDirectorate Change
17th Jun 20247:00 amRNSInaphaea Contract Award
28th May 20247:00 amRNSInvestor Webinar
20th May 202412:00 pmRNSBusiness Update
16th May 20247:00 amRNSFurther re Final Results
15th May 20247:00 amRNSFinal Results and Notice of AGM
22nd Apr 20247:00 amRNSDirectorate Changes
21st Mar 20247:00 amRNSEvaluation Agreement with Imperial College London
19th Mar 20247:00 amRNSBoard Re-structuring and update on requisition
4th Mar 20245:47 pmRNSShareholder Requisition Notice
4th Mar 20247:00 amRNSProposed Appointment of Non-Executive Director
29th Feb 20242:00 pmRNSProposed Appointment of Non-Executive Director
13th Feb 20242:20 pmRNSFurther re Shareholder Requisition Notice
9th Feb 20245:06 pmRNSShareholder Requisition Notice
19th Jan 20247:00 amRNSChange of Broker
18th Jan 20247:00 amRNSDirectorate Change
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
E2V
E2V.L
LSE
0.00%
GMS
Gulf Marine Services
LSE
-2.60%
WNER
Wt Wner Usd
LSE
0.00%
TPT
Topps Tiles
LSE
-2.20%
PLAZ
Plaza
LSE
0.00%
Trending
GEX
Georgina Energy
LSE
5.08%
ALRT
Defence Holdings
LSE
0.00%
BSFA
Bio-Sustainable Future Enterprises
LSE
-5.00%
MAC
Marechale Cap.
LSE
19.18%
PREM
Premier African Minerals
LSE
-6.00%